Cooperative Agreement U2CDK143937
Award Date 9/1/25
Completion Date 5/31/30
Dollars Obligated $369K
Awardee
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Minnesota, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $882,138 Project Grant to Mayo Clinic under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, titled "NEXT GENERATION KUH RESEARCHERS (GENERATOR) TRAINING CORE", will fund a research and career development program focused on predoctoral and postdoctoral scholars in kidney, urologic, and hematologic (KUH) research. The 5-year project aims to create a...
- This $278,893 Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support the development of the "Mountain States Advancement in Research, Supportive Networking and Career Development (ASCEND)" program. The program aims to create a comprehensive training pathway to recruit, develop, and retain future academic leaders in the fields of kidney, urology, and...
- The Houston Area Incubator for Kidney, Urologic, and Hematologic (HAI-KUH) Research Training Cooperative Agreement, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), will provide $368,743 to Baylor College of Medicine over a 5-year period from September 1, 2025 to May 31, 2030. The funding will support the development of a professional development program to enhance the skills and...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $882,138 to Baylor College of Medicine to develop the Houston Area Incubator for Kidney, Urologic and Hematologic Research Training (HAI-KUH). This program aims to build a highly qualified workforce to improve the health and quality of life of patients with kidney, urologic, and...
- This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $790,565.00 to the Mayo Clinic for the T1D-DN KPMP URBAN RURAL (T1D-DN KUR) RECRUITMENT SITE project starting September 1, 2025 and ending June 30, 2030. The goal of the project is to expand the Kidney Precision Medicine Project (KPMP) by recruiting individuals with type 1...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $414,267 Cooperative Agreement under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Washington. The goal of this 5-year project, titled "Polycystic Kidney Disease In Vitro Center (PKD-INVENT)", is to expand and enable the preclinical-to-clinical research pathway for polycystic kidney disease (PKD) by generating products, services, and...
- The federal Project Grant award of $237,750 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) is supporting a research study to examine nephrology practices' participation decisions and care model reforms under Medicare's Kidney Care Choices payment models. The study, conducted by the Trustees of Indiana University (UEI: SHHBRBAPSM35), aims to better understand how smaller...
- This Cooperative Agreement award of $2,367,892 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to develop and evaluate a novel approach to mitigate the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes (T1D) and chronic kidney disease (CKD) who are taking sodium-glucose cotransporter (SGLT) inhibitor medications. The project aims...
- This federal Project Grant award, in the amount of $531,999.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award is supporting research focused on understanding the role of alternative splicing in the proximal tubules of the kidney and its relationship to the progression of diabetic kidney disease. The research will investigate how diabetes...
- This Project Grant award, valued at $199,130.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The objective is to demonstrate the clinical utility of patient-reported outcome measures (PROMs) in the care of individuals with advanced chronic kidney disease (CKD). The award will fund research across two key areas: 1) developing and validating risk...